testosterone
Genito-urinary system and sex hormones (G03)US regulatory status: approved. Molecular target: Androgen receptor.
- Target
- Androgen receptor
- Mechanism
- Androgen Receptor agonist
pharma · Hypoactive Sexual Desire Disorder
anwerina Deutschland
Warner Chilcott Deutschland GmbH
anwerina Deutschland drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
mannheim, DE HQ
10 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- mannheim, DE
- Employees
- 10
- Programs
- 1
- Drugs
- 1
- Patents
- 0
anwerina Deutschland pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
anwerina Deutschland drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.